ACHC vs MD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

ACHC

37.6
AI Score
VS
MD Wins

MD

44.3
AI Score

Investment Advisor Scores

ACHC

38score
Recommendation
AVOID NEW MONEY

MD

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ACHC MD Winner
Forward P/E 15.8228 9.2937 MD
PEG Ratio 1.3745 0.2433 MD
Revenue Growth -0.4% 1.7% MD
Earnings Growth -63.6% -29.8% MD
Tradestie Score 37.6/100 44.3/100 MD
Profit Margin -33.4% 7.7% MD
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD MD

Relative Price Performance (Last 90 Days)

ACHC 1M: +28.5% · 3M: +21.9% MD 1M: +17.5% · 3M: +19.3%

Current Technical Phase

ACHC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.0% over 20 days), RSI 79

RSI (14): 79.3 · Price: $38.64

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.7% over 20 days), RSI 68

RSI (14): 68.3 · Price: $31.62

Fundamentals Snapshot

Metric ACHC MD
Market Cap — —
Forward P/E 19.1 12.8
Trailing P/E — 17.2
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.4% 0.3%
Operating Margin 0.1% 0.1%
EPS -12.44 1.83
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.